You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Express Scripts
Moodys
AstraZeneca
Harvard Business School

Last Updated: May 10, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for L-Phenylalanine

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug L-Phenylalanine?

L-Phenylalanine is an investigational drug.

There have been 85 clinical trials for L-Phenylalanine. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 1994.

The most common disease conditions in clinical trials are Multiple Myeloma, Neoplasms, Plasma Cell, and Lymphoma. The leading clinical trial sponsors are National Cancer Institute (NCI), Fred Hutchinson Cancer Research Center, and City of Hope Medical Center.

Recent Clinical Trials for L-Phenylalanine
TitleSponsorPhase
Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain CancerNational Cancer Institute (NCI)Phase 1
Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain CancerM.D. Anderson Cancer CenterPhase 1
Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple MyelomaNational Cancer Institute (NCI)Phase 1

See all L-Phenylalanine clinical trials

Clinical Trial Summary for L-Phenylalanine

Top disease conditions for L-Phenylalanine
Top clinical trial sponsors for L-Phenylalanine

See all L-Phenylalanine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Merck
McKinsey
Medtronic
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.